logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Cephalosporin Antibacterial class drugs

    FiltersReset Filters
    11 results

    • cefazolin

      (cefazolin sodium)
      Sagent Pharmaceuticals
      Usage: Cefazolin for Injection is indicated for treating serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections during contaminated surgeries. Its use should be guided by culture and susceptibility data.

    • cefazolin

      (Cefazolin Sodium)
      Baxter Healthcare Corporation
      Usage: Cefazolin in Dextrose Injection is indicated for treating respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, and endocarditis in adults and pediatric patients. It is also used for perioperative prophylaxis to reduce infection risk during certain surgeries. Limitations include its efficacy in preventing rheumatic fever.

    • cefazolin

      (Cefazolin)
      WG Critical Care, LLC
      Usage: Cefazolin for Injection, USP is indicated for serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections in high-risk surgical patients. Use is to treat or prevent targeted infections.

    • cefepime

      (Cefepime)
      WG Critical Care, LLC
      Usage: Cefepime is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections (with metronidazole). It should be used to target infections caused by susceptible bacteria to prevent drug resistance.

    • cefepime

      (cefepime)
      Baxter Healthcare Corporation
      Usage: Cefepime Injection is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections. It should be used to combat infections caused by specific susceptible bacteria to prevent drug resistance.

    • ceftriaxone

      (Ceftriaxone)
      WG Critical Care, LLC
      Usage: Ceftriaxone for Injection is indicated for treating various infections caused by susceptible bacteria, including lower respiratory tract infections, bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.

    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone is indicated for treating infections caused by susceptible bacteria, including lower respiratory tract infections, acute bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.

    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone is indicated for treating infections caused by susceptible bacteria, including lower respiratory infections, acute bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis against postoperative infections.

    • fetroja

      (Cefiderocol sulfate tosylate)
      Shionogi Inc.
      Usage: FETROJA® is indicated for patients aged 18 and older for treating complicated urinary tract infections (cUTIs) including pyelonephritis, and hospital-acquired/ventilator-associated bacterial pneumonia, caused by susceptible Gram-negative bacteria like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Use should limit drug resistance.

    • zerbaxa

      (ceftolozane and tazobactam)
      Merck Sharp & Dohme LLC
      Usage: ZERBAXA is indicated for the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), and hospital-acquired or ventilator-associated bacterial pneumonia in adults and pediatric patients, targeting specific susceptible Gram-negative and Gram-positive bacteria. Usage should be guided by culture results and epidemiology.